Marco Folci

2.1k total citations
20 papers, 588 citations indexed

About

Marco Folci is a scholar working on Rheumatology, Surgery and Molecular Biology. According to data from OpenAlex, Marco Folci has authored 20 papers receiving a total of 588 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Rheumatology, 5 papers in Surgery and 5 papers in Molecular Biology. Recurrent topics in Marco Folci's work include Vasculitis and related conditions (5 papers), Inflammasome and immune disorders (4 papers) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (4 papers). Marco Folci is often cited by papers focused on Vasculitis and related conditions (5 papers), Inflammasome and immune disorders (4 papers) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (4 papers). Marco Folci collaborates with scholars based in Italy, United States and Netherlands. Marco Folci's co-authors include Carlo Selmi, Enrico Brunetta, Francesca Meda, Andrea Baccarelli, Claudio Angelini, Raffaello Furlan, Enrico Heffler, Silvio Danese, Michele Ciccarelli and Daniele Piovani and has published in prestigious journals such as Journal of Controlled Release, Frontiers in Immunology and Frontiers in Physiology.

In The Last Decade

Marco Folci

20 papers receiving 572 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marco Folci Italy 12 148 120 114 91 83 20 588
Angela Wawer Germany 15 144 1.0× 52 0.4× 163 1.4× 108 1.2× 148 1.8× 25 710
Marco Rabusin Italy 15 60 0.4× 70 0.6× 195 1.7× 133 1.5× 67 0.8× 43 818
Zilda Najjar Prado de Oliveira Brazil 16 64 0.4× 160 1.3× 77 0.7× 67 0.7× 35 0.4× 53 720
Vinita Agrawal India 17 85 0.6× 146 1.2× 76 0.7× 133 1.5× 229 2.8× 115 984
Sheilagh Maguiness United States 19 87 0.6× 81 0.7× 96 0.8× 103 1.1× 69 0.8× 66 1.0k
Chenxiong Le United States 8 66 0.4× 87 0.7× 175 1.5× 78 0.9× 54 0.7× 11 512
Halûk Demiroğlu Türkiye 11 136 0.9× 48 0.4× 41 0.4× 56 0.6× 68 0.8× 75 551
Caterina Dianzani Italy 18 75 0.5× 89 0.7× 81 0.7× 81 0.9× 61 0.7× 59 928
Melchior Lauten Germany 19 116 0.8× 53 0.4× 110 1.0× 250 2.7× 110 1.3× 46 1.0k
B. Demirhan Türkiye 16 80 0.5× 65 0.5× 139 1.2× 131 1.4× 77 0.9× 64 771

Countries citing papers authored by Marco Folci

Since Specialization
Citations

This map shows the geographic impact of Marco Folci's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marco Folci with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marco Folci more than expected).

Fields of papers citing papers by Marco Folci

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marco Folci. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marco Folci. The network helps show where Marco Folci may publish in the future.

Co-authorship network of co-authors of Marco Folci

This figure shows the co-authorship network connecting the top 25 collaborators of Marco Folci. A scholar is included among the top collaborators of Marco Folci based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marco Folci. Marco Folci is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Folci, Marco, et al.. (2022). Autoinflammatory manifestations in adult patients. Clinical & Experimental Immunology. 210(3). 295–308. 6 indexed citations
2.
Folci, Marco, et al.. (2021). Eosinophils as Major Player in Type 2 Inflammation: Autoimmunity and Beyond. Advances in experimental medicine and biology. 1347. 197–219. 25 indexed citations
3.
Folci, Marco, et al.. (2021). The biology, pathogenetic role, clinical implications, and open issues of serum anti-neutrophil cytoplasmic antibodies. Autoimmunity Reviews. 20(3). 102759–102759. 30 indexed citations
4.
Folci, Marco, et al.. (2021). Serum ANCA as Disease Biomarkers: Clinical Implications Beyond Vasculitis. Clinical Reviews in Allergy & Immunology. 63(2). 107–123. 13 indexed citations
5.
Brunetta, Enrico, Marco Folci, Maria De Santis, et al.. (2021). Serum ANCA and Overall Mortality: A 10-Year Retrospective Cohort Study on 1,024 Italian Subjects. Frontiers in Immunology. 12. 714174–714174. 2 indexed citations
6.
Folci, Marco, et al.. (2020). Biomarkers and Diagnostic Testing for Renal Disease in Sjogren's Syndrome. Frontiers in Immunology. 11. 562101–562101. 13 indexed citations
7.
Cecconi, Maurizio, Daniele Piovani, Enrico Brunetta, et al.. (2020). Early Predictors of Clinical Deterioration in a Cohort of 239 Patients Hospitalized for Covid-19 Infection in Lombardy, Italy. Journal of Clinical Medicine. 9(5). 1548–1548. 126 indexed citations
8.
Minonzio, Maura, Enrico Brunetta, Dana Shiffer, et al.. (2020). Cardiovascular Autonomic Control during Respiratory Paced Hypnosis. 1–2. 1 indexed citations
9.
Schroeder, Jan Walter, Marco Folci, Laura Losappio, et al.. (2019). Anti-Neutrophil Cytoplasmic Antibodies Positivity and Anti-Leukotrienes in Eosinophilic Granulomatosis with Polyangiitis: A Retrospective Monocentric Study on 134 Italian Patients. International Archives of Allergy and Immunology. 180(1). 64–71. 13 indexed citations
10.
Brunetta, Enrico, Dana Shiffer, Marco Folci, et al.. (2019). Autonomic Abnormalities in Patients With Primary Sjogren’s Syndrome – Preliminary Results. Frontiers in Physiology. 10. 1104–1104. 10 indexed citations
11.
Folci, Marco, et al.. (2019). ANCA-Associated Vasculitides and Hematologic Malignancies: Lessons from the Past and Future Perspectives. Journal of Immunology Research. 2019. 1–9. 17 indexed citations
12.
Filgueira, Carly S., Giacomo Bruno, Corrine Ying Xuan Chua, et al.. (2018). Efficacy of sustained delivery of GC-1 from a Nanofluidic system in a spontaneously obese non-human primate: a case study. Biomedical Microdevices. 20(2). 49–49. 5 indexed citations
13.
Chua, Corrine Ying Xuan, Priya Jain, Andrea Ballerini, et al.. (2018). Transcutaneously refillable nanofluidic implant achieves sustained level of tenofovir diphosphate for HIV pre-exposure prophylaxis. Journal of Controlled Release. 286. 315–325. 66 indexed citations
14.
Chua, Corrine Ying Xuan, Priya Jain, Jessica Rhudy, et al.. (2018). Nanofluidic drug-eluting seed for sustained intratumoral immunotherapy in triple negative breast cancer. Journal of Controlled Release. 285. 23–34. 50 indexed citations
15.
Folci, Marco, Enrico Heffler, Giorgio Walter Canonica, Raffaello Furlan, & Enrico Brunetta. (2018). Cutting Edge: Biomarkers for Chronic Spontaneous Urticaria. Journal of Immunology Research. 2018. 1–12. 34 indexed citations
16.
Brunetta, Enrico, Dana Shiffer, Marco Folci, et al.. (2018). Omalizumab for Idiopathic Nonhistaminergic Angioedema: Evidence for Efficacy in 2 Patients. PubMed. 2018. 1–3. 9 indexed citations
17.
Generali, Elena, Marco Folci, Carlo Selmi, & Piersandro Riboldi. (2017). Immune-Mediated Heart Disease. Advances in experimental medicine and biology. 1003. 145–171. 11 indexed citations
18.
Folci, Marco & F. Capsoni. (2016). Arthralgias, fatigue, paresthesias and visceral pain: can joint hypermobility solve the puzzle? A case report. BMC Musculoskeletal Disorders. 17(1). 58–58. 7 indexed citations
19.
Folci, Marco, et al.. (2011). Cutting-Edge Issues in Primary Biliary Cirrhosis. Clinical Reviews in Allergy & Immunology. 42(3). 342–354. 15 indexed citations
20.
Meda, Francesca, Marco Folci, Andrea Baccarelli, & Carlo Selmi. (2011). The epigenetics of autoimmunity. Cellular and Molecular Immunology. 8(3). 226–236. 135 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026